BioNTech SE logo

BioNTech SE - ADR

WBO:BNTX (Germany)   ADR
€ 81.20 (+0.62%) Apr 19
20.94
P/B:
0.93
Market Cap:
€ 19.61B ($ 20.89B)
Enterprise V:
€ 3.28B ($ 3.49B)
Volume:
-
Avg Vol (2M):
48.00
Also Trade In:

Business Description

Description
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.
Name Current Vs Industry Vs History
Cash-To-Debt 75.53
Equity-to-Asset 0.88
Debt-to-Equity 0.01
Debt-to-EBITDA 0.2
Interest Coverage 25.41
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 6.59
Distress
Grey
Safe
Beneish M-Score -2.66
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 30.64
9-Day RSI 34.85
14-Day RSI 38.53
6-1 Month Momentum % -0.91
12-1 Month Momentum % -21.36

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 9.43
Quick Ratio 9.26
Cash Ratio 7.99
Days Inventory 252.61
Days Sales Outstanding 387.28
Days Payable 126.27

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio 0.5
Shareholder Yield % 3.87

Financials (Next Earnings Date:2024-05-08 Est.)

WBO:BNTX's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

BioNTech SE Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 3,819
EPS (TTM) (€) 3.82
Beta 0.61
Volatility % 28.46
14-Day RSI 38.53
14-Day ATR (€) 1.211052
20-Day SMA (€) 83.2405
12-1 Month Momentum % -21.36
52-Week Range (€) 80.18 - 115.25
Shares Outstanding (Mil) 240.99

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

BioNTech SE Filings

Filing Date Document Date Form
No Filing Data

BioNTech SE Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

BioNTech SE Frequently Asked Questions

What is BioNTech SE(WBO:BNTX)'s stock price today?
The current price of WBO:BNTX is €81.20. The 52 week high of WBO:BNTX is €115.25 and 52 week low is €80.18.
When is next earnings date of BioNTech SE(WBO:BNTX)?
The next earnings date of BioNTech SE(WBO:BNTX) is 2024-05-08 Est..
Does BioNTech SE(WBO:BNTX) pay dividends? If so, how much?
BioNTech SE(WBO:BNTX) does not pay dividend.

Press Release

Subject Date
No Press Release